title: Costs related to drugs produced by recombinant DNA technology.
authors.forename: D
authors.initials: D
authors.lastname: Antier
authors.forename: C
authors.initials: C
authors.lastname: Vantyghem
authors.forename: F
authors.initials: F
authors.lastname: Triaud
authors.forename: M
authors.initials: M
authors.lastname: Le Verger
authors.forename: J
authors.initials: J
authors.lastname: Grassin
mesh_terms: D002017:Budgets; D003365:Costs and Cost Analysis; D005602:France; D006801:Humans; D011994:Recombinant Proteins / Q000191:economics*
chemical_list: D011994:Recombinant Proteins